Heuron Co.

Healthcare ITSeries BSeoul, South Koreaiheuron.com

Latest round

Series B

Last raised

Jul 2020

Total raised

$15M

Investors

7

About Heuron Co.

, Ltd. operates as a medical AI development company that provides treatment solutions for central nervous system disorders. The company's president and chief executive officer Donghoon Shin graduated from Ajou University College of Medicine. He is an associate professor at Gachon University Gil Medical Center. In February 2021, it obtained NET(New Excellent Technology) certification for Nigrosome biomarker discovery technology in MR imaging. In July 2020, it obtained MFDS (Class II) certification for Medical Image Analysis Device Software. The company has partnerships with Ajou University Hospital, Gangnam Severance Hospital, and Seoul St. Mary's Hospital. The company has more than 20 clinical data-centered diagnostic programs under development for Parkinson's disease, dementia, stroke, and brain tumors?. The company has developed AI software enabling early diagnosis of degenerative diseases of the brain.

Who invested in Heuron Co.

7 investors across 2 rounds

See all investors in Heuron Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jul 16, 2020

    Amount

    $13M

    Investors

    Locked

  2. Series A

    Jul 2, 2019

    Amount

    $2.6M

    Investors

    Locked

Questions about Heuron Co.

Who invested in Heuron Co.?

Heuron Co. has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Heuron Co. raised?

Heuron Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Heuron Co. last raise money?

Heuron Co.'s most recent round on record is a Series B, in Jul 2020.

What does Heuron Co. do?

Heuron Co. is a healthcare it company.

Where is Heuron Co. headquartered?

Heuron Co. is headquartered in Seoul, South Korea.

Which VCs invest in companies like Heuron Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare it companies at Heuron Co.'s stage. Their profiles are linked below.

Raising like Heuron Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.